有机阴离子转运多肽
Organic anion-transporting polypeptides.
作者信息
Stieger Bruno, Hagenbuch Bruno
机构信息
Department of Clinical Pharmacology and Toxicology, University Hospital, Zürich, Switzerland.
Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas, USA.
出版信息
Curr Top Membr. 2014;73:205-32. doi: 10.1016/B978-0-12-800223-0.00005-0.
Abstract
Organic anion-transporting polypeptides or OATPs are central transporters in the disposition of drugs and other xenobiotics. In addition, they mediate transport of a wide variety of endogenous substrates. The critical role of OATPs in drug disposition has spurred research both in academia and in the pharmaceutical industry. Translational aspects with clinical questions are the focus in academia, while the pharmaceutical industry tries to define and understand the role these transporters play in pharmacotherapy. The present overview summarizes our knowledge on the interaction of food constituents with OATPs and on the OATP transport mechanisms. Further, it gives an update on the available information on the structure-function relationship of the OATPs and, finally, covers the transcriptional and posttranscriptional regulation of OATPs.
摘要
有机阴离子转运多肽（OATPs）是药物和其他外源性物质处置过程中的关键转运蛋白。此外，它们还介导多种内源性底物的转运。OATPs在药物处置中的关键作用激发了学术界和制药行业的研究。学术界关注与临床问题相关的转化研究，而制药行业则试图确定并理解这些转运蛋白在药物治疗中所起的作用。本综述总结了我们关于食物成分与OATPs相互作用以及OATPs转运机制的知识。此外，它还更新了有关OATPs结构-功能关系的现有信息，最后涵盖了OATPs的转录和转录后调控。
相似文献
1
Organic anion-transporting polypeptides.有机阴离子转运多肽
Curr Top Membr. 2014;73:205-32. doi: 10.1016/B978-0-12-800223-0.00005-0.
2
Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.有机阴离子转运体家族和有机阴离子转运多肽家族中主要药物转运体的翻译后调控。
J Biol Chem. 2020 Dec 11;295(50):17349-17364. doi: 10.1074/jbc.REV120.009132. Epub 2020 Oct 13.
3
Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters.有机阴离子多肽转运体介导的pH梯度驱动转运机制。
Am J Physiol Cell Physiol. 2009 Mar;296(3):C570-82. doi: 10.1152/ajpcell.00436.2008. Epub 2009 Jan 7.
4
Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family.人类有机阴离子转运多肽（OATP）家族的外源性物质转运体。
Xenobiotica. 2008 Jul;38(7-8):778-801. doi: 10.1080/00498250801986951.
5
The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions.有机阴离子转运多肽在药物吸收、分布、排泄及药物相互作用中的作用。
Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):409-424. doi: 10.1080/17425255.2017.1253679. Epub 2016 Nov 9.
6
Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties.OATP/SLC21家族的有机阴离子转运多肽：作为OATP/SLCO超家族的系统发育分类、新命名法及分子/功能特性
Pflugers Arch. 2004 Feb;447(5):653-65. doi: 10.1007/s00424-003-1168-y. Epub 2003 Oct 25.
7
Organic anion transporting polypeptides (OATPs): regulation of expression and function.有机阴离子转运多肽（OATPs）：表达和功能的调节。
Curr Drug Metab. 2011 Feb;12(2):139-53. doi: 10.2174/138920011795016863.
8
Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.有机阴离子转运多肽（OATPs）在癌症治疗中的作用。
AAPS J. 2015 May;17(3):535-45. doi: 10.1208/s12248-015-9740-x. Epub 2015 Mar 4.
9
OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.OATPs、OATs 和 OCTs：SLCO 和 SLC22A 基因超家族的有机阴离子和阳离子转运体。
Br J Pharmacol. 2012 Mar;165(5):1260-87. doi: 10.1111/j.1476-5381.2011.01724.x.
10
Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.有机阴离子转运多肽（OATPs）在药物处置中的临床意义：它们在肝脏清除和肠道吸收中的作用。
Biopharm Drug Dispos. 2013 Jan;34(1):45-78. doi: 10.1002/bdd.1823.
引用本文的文献
1
Differential Expression Patterns of SLCO Solute Carriers in Human Breast Cancer Cell Lines and Tumour Samples.人类乳腺癌细胞系和肿瘤样本中溶质载体有机阴离子转运体家族（SLCO）的差异表达模式
J Cell Mol Med. 2025 Sep;29(17):e70838. doi: 10.1111/jcmm.70838.
2
Subchronic Exposure to Microcystin-LR Induces Hepatic Inflammation, Oxidative Stress, and Lipid Metabolic Disorders in Darkbarbel Catfish ().亚慢性暴露于微囊藻毒素-LR会诱导暗纹东方鲀肝脏发生炎症、氧化应激和脂质代谢紊乱（）。
Toxins (Basel). 2025 Jun 12;17(6):300. doi: 10.3390/toxins17060300.
3
ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches.ATP结合盒转运体与溶质载体转运体：通过结构和建模方法理解其机制及药物调控
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1602. doi: 10.3390/ph17121602.
4
The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review.胆红素在肝脏疾病中的多方面作用：文献综述
J Clin Transl Hepatol. 2024 Nov 28;12(11):939-948. doi: 10.14218/JCTH.2024.00156. Epub 2024 Oct 21.
5
The Competitive Counterflow Assay for Identifying Drugs Transported by Solute Carriers: Principle, Applications, Challenges/Limits, and Perspectives.竞争逆流分析法鉴定溶质载体转运的药物：原理、应用、挑战/限制及展望。
Eur J Drug Metab Pharmacokinet. 2024 Sep;49(5):527-539. doi: 10.1007/s13318-024-00902-7. Epub 2024 Jul 3.
6
Microcystin-leucine arginine induces the proliferation of cholangiocytes and cholangiocarcinoma cells through the activation of the Wnt/β-catenin signaling pathway.微囊藻毒素-亮氨酸精氨酸通过激活Wnt/β-连环蛋白信号通路诱导胆管细胞和胆管癌细胞增殖。
Heliyon. 2024 Apr 26;10(9):e30104. doi: 10.1016/j.heliyon.2024.e30104. eCollection 2024 May 15.
7
Antibody-blocking of a tick transporter impairs Anaplasma phagocytophilum colonization in Haemaphysalis longicornis ticks.抗体阻断蜱的转运蛋白可损害嗜吞噬细胞无形体在长角血蜱中的定殖。
Sci Rep. 2024 Apr 18;14(1):9003. doi: 10.1038/s41598-024-59315-w.
8
SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.SLCO4A1作为一种非小细胞肺癌的新型预后生物标志物，可促进细胞增殖和迁移。
Int J Oncol. 2024 Mar;64(3). doi: 10.3892/ijo.2024.5618. Epub 2024 Jan 26.
9
Quantification of OATP1B1 endogenous metabolites coproporphyrin I and III in human urine.人尿中OATP1B1内源性代谢物粪卟啉I和III的定量分析。
Transl Clin Pharmacol. 2023 Sep;31(3):139-147. doi: 10.12793/tcp.2023.31.e12. Epub 2023 Aug 23.
10
The Double-Leucine Motifs Affect Internalization, Stability, and Function of Organic Anion Transporting Polypeptide 1B1.双亮氨酸基序影响有机阴离子转运多肽1B1的内化、稳定性及功能。
Pharmaceutics. 2023 Sep 4;15(9):2279. doi: 10.3390/pharmaceutics15092279.
本文引用的文献
1
Oatp1a1 requires PDZK1 to traffic to the plasma membrane by selective recruitment of microtubule-based motor proteins.Oatp1a1 通过选择性招募基于微管的马达蛋白将 PDZK1 运输到质膜。
Drug Metab Dispos. 2014 Jan;42(1):62-9. doi: 10.1124/dmd.113.054536. Epub 2013 Oct 10.
2
Polyphenols: benefits to the cardiovascular system in health and in aging.多酚：对健康和衰老中心血管系统的益处。
Nutrients. 2013 Sep 26;5(10):3779-827. doi: 10.3390/nu5103779.
3
Organic anion-transporting polypeptides: a novel approach for cancer therapy.有机阴离子转运多肽：癌症治疗的新途径。
J Drug Target. 2014 Jan;22(1):14-22. doi: 10.3109/1061186X.2013.832767. Epub 2013 Aug 29.
4
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.近年来，利用原代肝细胞、替代的肝细胞来源和非实质细胞的 2D 和 3D 体外系统在研究肝毒性、细胞信号转导和 ADME 的机制方面取得了进展。
Arch Toxicol. 2013 Aug;87(8):1315-530. doi: 10.1007/s00204-013-1078-5. Epub 2013 Aug 23.
5
Role of hypoxia inducible factor-1α in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer.缺氧诱导因子-1α 在调节结肠癌和胰腺癌中有机阴离子转运多肽 1B3（OATP1B3）的肿瘤特异性变体中的作用。
Biochem Pharmacol. 2013 Sep 15;86(6):816-23. doi: 10.1016/j.bcp.2013.07.020. Epub 2013 Aug 4.
6
Conserved tryptophan residues within putative transmembrane domain 6 affect transport function of organic anion transporting polypeptide 1B1.位于假定跨膜域 6 内的保守色氨酸残基影响有机阴离子转运多肽 1B1 的转运功能。
Mol Pharmacol. 2013 Oct;84(4):521-7. doi: 10.1124/mol.113.085977. Epub 2013 Jul 15.
7
Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines.有机阴离子转运多肽 1B3 在癌细胞系中的表观遗传调控。
Pharm Res. 2013 Nov;30(11):2880-90. doi: 10.1007/s11095-013-1117-1. Epub 2013 Jun 28.
8
Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin.水飞蓟宾抑制肝细胞有机阴离子转运多肽（OATPs）和多药耐药相关蛋白 2（MRP2）。
Drug Metab Dispos. 2013 Aug;41(8):1522-8. doi: 10.1124/dmd.113.051037. Epub 2013 May 21.
9
Transporters and drug-drug interactions: important determinants of drug disposition and effects.转运体和药物-药物相互作用：影响药物处置和效应的重要决定因素。
Pharmacol Rev. 2013 May 17;65(3):944-66. doi: 10.1124/pr.113.007518. Print 2013 Jul.
10
Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.细胞内药物浓度和转运体：测量、建模及其对肝脏的影响。
Clin Pharmacol Ther. 2013 Jul;94(1):126-41. doi: 10.1038/clpt.2013.78. Epub 2013 Apr 10.
Zotero 插件